View in EDS PDF Full Text

Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.

Saved in:
Bibliographic Details
Title: Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
Authors: Cook LB; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., O'Dell G; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Vourvou E; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Palanicawandar R; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Marks S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Milojkovic D; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Apperley JF; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Loaiza S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Claudiani S; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Bua M; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Hockings C; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Macdonald D; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Chaidos A; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Pavlu J; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Cooper N; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK., Fidler S; Section of Virology, Faculty of Medicine, Department of Infectious Diseases, Imperial College London, London, UK., Randell P; Department of Infection and Immunity, North West London Pathology, London, UK., Innes AJ; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK. a.innes@imperial.ac.uk.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK. a.innes@imperial.ac.uk.
Source: Nature communications [Nat Commun] 2022 Nov 14; Vol. 13 (1), pp. 6922. Date of Electronic Publication: 2022 Nov 14.
Publication Type: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36376307
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cook+LB%22">Cook LB</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22O'Dell+G%22">O'Dell G</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Vourvou+E%22">Vourvou E</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Palanicawandar+R%22">Palanicawandar R</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Marks+S%22">Marks S</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Milojkovic+D%22">Milojkovic D</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Apperley+JF%22">Apperley JF</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Loaiza+S%22">Loaiza S</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Claudiani+S%22">Claudiani S</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Bua+M%22">Bua M</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Hockings+C%22">Hockings C</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Macdonald+D%22">Macdonald D</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Chaidos+A%22">Chaidos A</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Pavlu+J%22">Pavlu J</searchLink>; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Cooper+N%22">Cooper N</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Fidler+S%22">Fidler S</searchLink>; Section of Virology, Faculty of Medicine, Department of Infectious Diseases, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Randell+P%22">Randell P</searchLink>; Department of Infection and Immunity, North West London Pathology, London, UK.<br /><searchLink fieldCode="AU" term="%22Innes+AJ%22">Innes AJ</searchLink>; Centre for Haematology, Faculty of Medicine, Department of Immunology and Inflammation, Imperial College London, London, UK. a.innes@imperial.ac.uk.; Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK. a.innes@imperial.ac.uk.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2022 Nov 14; Vol. 13 (1), pp. 6922. <i>Date of Electronic Publication: </i>2022 Nov 14.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Observational Study; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36376307
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-022-34657-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 6922
    Titles:
      – TitleFull: Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cook LB
      – PersonEntity:
          Name:
            NameFull: O'Dell G
      – PersonEntity:
          Name:
            NameFull: Vourvou E
      – PersonEntity:
          Name:
            NameFull: Palanicawandar R
      – PersonEntity:
          Name:
            NameFull: Marks S
      – PersonEntity:
          Name:
            NameFull: Milojkovic D
      – PersonEntity:
          Name:
            NameFull: Apperley JF
      – PersonEntity:
          Name:
            NameFull: Loaiza S
      – PersonEntity:
          Name:
            NameFull: Claudiani S
      – PersonEntity:
          Name:
            NameFull: Bua M
      – PersonEntity:
          Name:
            NameFull: Hockings C
      – PersonEntity:
          Name:
            NameFull: Macdonald D
      – PersonEntity:
          Name:
            NameFull: Chaidos A
      – PersonEntity:
          Name:
            NameFull: Pavlu J
      – PersonEntity:
          Name:
            NameFull: Cooper N
      – PersonEntity:
          Name:
            NameFull: Fidler S
      – PersonEntity:
          Name:
            NameFull: Randell P
      – PersonEntity:
          Name:
            NameFull: Innes AJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 11
              Text: 2022 Nov 14
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1